Basit öğe kaydını göster

Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?

dc.contributor.authorGuzel, Deniz Kamalak
dc.contributor.authorTuna, Nazan
dc.contributor.authorKinikli, Sami
dc.contributor.authorİNAN, DİLARA
dc.contributor.authorERSÖZ, GÜLDEN
dc.contributor.authorSimsek, Funda
dc.contributor.authorTulek, Necla
dc.contributor.authorTarakci, Huseyin
dc.contributor.authorYILDIZ, ORHAN
dc.contributor.authorTurkoglu, Emine
dc.contributor.authorSimsek, Sumeyra
dc.contributor.authorBatirel, Ayse
dc.contributor.authorURAL, ONUR
dc.contributor.authorBarut, Sener
dc.contributor.authorKuruuzum, Ziya
dc.contributor.authorSener, Alper
dc.contributor.authorOzel, Selcan Arslan
dc.contributor.authorOzturk, Sinan
dc.contributor.authorSuer, Kaya
dc.contributor.authorÇELEN, MUSTAFA KEMAL
dc.contributor.authorKonya, Petek
dc.contributor.authorAsan, Ali
dc.contributor.authorSALTOĞLU, Neşe
dc.contributor.authorDogan, Nurhan
dc.contributor.authorAKHAN, SILA
dc.contributor.authorMistik, Resit
dc.contributor.authorCelik, Ilhami
dc.contributor.authorAYGEN, BİLGEHAN
dc.contributor.authorDemirturk, Nese
dc.contributor.authorSİLİ, ULUHAN
dc.contributor.authorKORKMAZ, PINAR
dc.contributor.authorOrmen, Bahar
dc.contributor.authorErtem, Gunay Tuncer
dc.contributor.authorHakyemez, Ismail Necati
dc.contributor.authorKARAKEÇİLİ, FARUK
dc.contributor.authorCetinkaya, Riza Aytac
dc.contributor.authorCagatay, Atahan
dc.contributor.authorDEMİR, NAZLIM AKTUĞ
dc.contributor.authorTurker, Nesrin
dc.contributor.authorBİLGİN, HÜSEYİN
dc.contributor.authorGurbuz, Yunus
dc.date.accessioned2021-12-10T11:35:41Z
dc.date.available2021-12-10T11:35:41Z
dc.date.issued2021
dc.identifier.citationDemirturk N., AYGEN B., Celik I., Mistik R., AKHAN S., Barut S., URAL O., Batirel A., Simsek F., ERSÖZ G., et al., "Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?", TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.32, sa.2, ss.155-163, 2021
dc.identifier.issn2148-5607
dc.identifier.othervv_1032021
dc.identifier.otherav_87c1a8ca-205a-4345-87a2-a55ba3159476
dc.identifier.urihttp://hdl.handle.net/20.500.12627/172204
dc.identifier.urihttps://doi.org/10.5152/tjg.2020.19569
dc.description.abstractBackground: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp
dc.subjectHealth Sciences
dc.subjectHepatology
dc.subjectGastroenterology
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectİç Hastalıkları
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleReal-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF GASTROENTEROLOGY
dc.contributor.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi , ,
dc.identifier.volume32
dc.identifier.issue2
dc.identifier.startpage155
dc.identifier.endpage163
dc.contributor.firstauthorID2637937


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster